BLISS GVS PHARMA
Back to Income Statement
|
BLISS GVS PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹770 Cr | ₹752 Cr | ₹747 Cr | ₹577 Cr | ₹689 Cr |
What is the latest Revenue of BLISS GVS PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹770 Cr |
| Mar2024 | ₹752 Cr |
| Mar2023 | ₹747 Cr |
| Mar2022 | ₹577 Cr |
| Mar2021 | ₹689 Cr |
How is Revenue of BLISS GVS PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹770 Cr | 2.48 | |
| Mar2024 | ₹752 Cr | 0.55 | |
| Mar2023 | ₹747 Cr | 29.50 | |
| Mar2022 | ₹577 Cr | -16.26 | |
| Mar2021 | ₹689 Cr | - | |
Compare Revenue of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,926.6 Cr | 11.8% | 12.2% | 12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,631.0 Cr | 1.9% | -0.8% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,111.0 Cr | 3.2% | 4.8% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,228.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹117,983.0 Cr | -3.3% | -2% | -1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,782.0 Cr | -3.8% | -3.1% | -8% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 11.8% |
12.2% |
12% |
| SENSEX | -1.2% |
-1.1% |
6.3% |
You may also like the below Video Courses